Command Palette

Search for a command to run...

ACCPL

58.7+0.00%
Market Cap
₹0.00 Cr
Stock P/E
0.00
ROCE
0.00%
ROE
0.00%
Book Value
₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Broad-Based Selling

Accretion Pharmaceuticals Ltd. is in a competitive pharmaceutical landscape with peers showing varied strengths in growth, profitability, and valuation. Companies like Dr. Reddy's Laboratories and Cipla stand out for their profitability, while firms like Divi's Laboratories show concerning growth metrics. Overall, the analysis reveals a mix of strong performers and financially risky companies, indicating a need for careful selection in the sector.

Key Points
  • Dr. Reddy's Laboratories and Cipla lead in profitability metrics.
  • Divi's Laboratories shows disappointing growth rates, indicating potential financial stress.
  • Cipla and Dr. Reddy's Laboratories are top value picks with low PE ratios and strong margins.
Top Performers
Dr. Reddy's Laboratories Ltd.

Highest ROE and ROCE, strong EPS growth, and low PE ratio.

Cipla Ltd.

High profitability with solid ROA and ROE, attractive valuation metrics.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.